1. DRUG PERTURBATION BASED STRATIFICATION OF LYMPHOPROLIFERATIVE DISORDERS. (June 2017) Authors: Dietrich, S.; Oleś, M.; Sellner, L.; Anders, S.; Lu, J.; Velten, B.; Mock, A.; Oakes, C.; Sutton, L.; Young, E.; Rosenquist, R.; Rossi, D.; Zirlik, K.; Herling, M.; Nguyen‐Khac, F.; Plass, C.; von Kalle, C.; Dürig, J.; Ringshausen, I.; Huber, W. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mutant KIT as imatinib-sensitive target in metastatic sinonasal carcinoma. (29th September 2016) Authors: Dieter, S. M.; Heining, C.; Agaimy, A.; Huebschmann, D.; Bonekamp, D.; Hutter, B.; Ehrenberg, K. R.; Fröhlich, M.; Schlesner, M.; Scholl, C.; Schlemmer, H.-P.; Wolf, S.; Mavratzas, A.; Jung, C. S.; Gröschel, S.; von Kalle, C.; Eils, R.; Brors, B.; Penzel, R.; Kriegsmann, M. Journal: Annals of oncology Issue: Volume 28:Number 1(2017) Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗